|
|
Hepatitis A & B Prevention by Vaccination: NP CACHE (Change Agents Championing Health Equity)
|
|
Facebook
LinkedIn
E-Mail
|
(522)
|
Released: 07/12/2024
Expires: 07/31/2025 (subject to change)
- CE for this activity will not be available after this date.
| This activity includes closed captioning. |
| Delivery Note: The content for this activity was previously presented during the 2024 AANP National Conference. If you already completed the content of this activity (session ID 24.3.038) while attending the live or virtual conference, you should not complete this content a second time. Learners should only complete ONE delivery-method to earn credit. Completing multiple delivery options for the same activity is considered duplicate credit for the same content and will not be accepted by regulatory bodies. |
Overview
Hepatitis A and B are both vaccine-preventable illnesses. Since the addition of the hepatitis A & B vaccines to routine immunization schedules in the 1980s and 1990s, the frequency of outbreaks and incidence of infections has declined significantly and is expected to avert more than 14 million premature deaths globally by 2030. However, in recent years, progress in the prevention of hepatitis has stalled, especially in key populations, including those who inject drugs, unhoused, men who have sex with me, and among those of Asian, Pacific Island, and Black people compared with White people. This ongoing transmission of Hepatitis A and B has been, in part, attributed to suboptimal vaccination rates among adults, especially those with risk factors for infection. This CE activity will provide NPs with the latest information on hepatitis A and B vaccine recommendations as well as evidence-based strategies for the implementation of updated CDC immunization guidelines in real-world practice.
For additional continuing education credit related to Hepatitis A & B Vaccination, register for and listen to the supplemental accredited podcast Hepatitis A&B Prevention by Vaccines: Strategies for Overcoming Barriers to Care. In this podcast, nurse practitioners Audrey Stevenson and Jessica Crimaldi review adult and child vaccination programs, eligibility status of adults and which populations are most at risk for infection, the NP’s role in promoting vaccines and solutions for vaccines during outbreaks.
Objectives - Review transmission patterns, risk factors, and burden of hepatitis A and B infections in the United States.
- Identify adult populations who are at risk for hepatitis A and B infections.
- Integrate the latest guideline recommendations for hepatitis A and B vaccination into clinical practice.
- Apply strategies to improve uptake of hepatitis A and B vaccination in indicated adult populations, including those from historically marginalized communities.
Speakers
Audrey Stevenson PhD, MPH, MSN, FNP-BC
Jessica Crimaldi MSN, APRN.CNP, CMSRN
Disclosure
This program was planned in accordance with AANP CE Standards and Policies.The speakers have the following disclosures: - Audrey Stevenson
- Advisory Board: Merck, Sanofi, Seqirus
- Speaker’s Bureau: GlaxoSmithKline, Sanofi, Seqirus
- Jessica Crimaldi
- No financial relationships to disclose.
All relevant financial relationships have been mitigated.All Planners involved in this activity have no relevant financial relationships to disclose.This educational activity is supported by an independent medical education grant from GSK.
Disclaimer
Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions- Read this activity description, including objectives and disclosures.
- Complete the Pretest associated to the activity.
- Complete the educational content:
- Video Presentations: Click the Play button to watch the activity presentation. Full participation credit for the activity will be received once the entire video has been watched.
- Click on the Additional Resources button to review all additional materials provided (handouts, post-test reviews, any other downloadable resources).
- After completing all content, click on the blue Next Steps button:
- Complete the post-test.
- Submit the evaluation to receive continuing education credit.
Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
1 Contact Hour(s) of CE,
0.66 of which may be applied towards Pharmacology
|
|
|
|
Adding Registration, Please wait...
